Cargando…
Adjuvant chemotherapy after radical cystectomy: Do all patients who need chemotherapy after surgery actually receive it?
BACKGROUND: Compliance with the guideline recommendations for neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is incomplete. The adjuvant chemotherapy approach has the advantage of pathology-based decision-making, allowing for patient selection. In addition, radical surgery...
Autores principales: | Croock, Roy, Modai, Jonathan, Avda, Yuval, Shpunt, Igal, Jaber, Morad, Peretz, Yamit, Shilo, Yaniv, Leibovici, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10489465/ https://www.ncbi.nlm.nih.gov/pubmed/37691991 http://dx.doi.org/10.1097/CU9.0000000000000099 |
Ejemplares similares
-
Potential Markers to Reduce Non-Contrast Computed Tomography Use for Symptomatic Patients with Suspected Ureterolithiasis
por: Avda, Yuval, et al.
Publicado: (2022) -
When should we give up on expectant management for patients with proximal ureteral stones?
por: Shpunt, Igal, et al.
Publicado: (2022) -
Fascial dehiscence after radical cystectomy: Is abdominal exploration mandatory?
por: Lotan, Paz, et al.
Publicado: (2022) -
The Impact of Radiographic, Metabolic and Demographic Characteristics on Kidney Stone Recurrence
por: Shpunt, Igal, et al.
Publicado: (2022) -
Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer
por: Pak, Sahyun, et al.
Publicado: (2019)